
Kezeles Pharmaceuticals Private Limited
Founded in 2012 and headquartered in Delhi, India.
Founded in 2012 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U85100DL2012PTC233046
233046
Private Limited Indian Non-Government Company
16 Mar 2012
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chinmaya Samal ![]() | Director | 16-Mar-2012 | Current |
Rashmi Nayak ![]() | Director | 16-Mar-2012 | Current |
Ashadeep Mohanty ![]() | Director | 16-Mar-2012 | Current |
Shradha Dhal ![]() | Director | 16-Mar-2012 | Current |
Enhance accessibility to Kezeles Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Kezeles Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kezeles Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kezeles Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kezeles Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chinmaya Chiranjibi Samal was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 2 months .
Rashmi Ranjan Nayak was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 2 months .
Ashadeep Mohanty was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 2 months .
Shradha Ranjan Dhal was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 2 months .
Kezeles Pharmaceuticals Private Limited was registered on 16 Mar 2012 with Roc Delhi & aged 13 years 2 months as per MCA records.
Kezeles Pharmaceuticals Private Limited was incorporated on 16 Mar 2012.
The authorized share capital of Kezeles Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 4 directors are associated with Kezeles Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kezeles Pharmaceuticals Private Limited is Jf-48 Khirki Extension Gupta Colony, Malviya Nagar India, New Delhi, 110017.
The corporate identification number (CIN) of Kezeles Pharmaceuticals Private Limited is U85100DL2012PTC233046 and the company number is 233046 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.